Grant: Master's Award: Canada Graduate Scholarships
University of Alberta
$17,500.00
Role of gangliosides in the secretion of extracellular vesicles in neurodegenerative disease
FY 2018-19
Summary
Gangliosides are glycosphingolipids enriched in the brain with important roles in cell signaling, cell-cell communication and immune-modulation. Their levels are decreased in several neurodegenerative conditions, including Huntington’s disease (HD) and Parkinson’s disease (PD). Therapeutic administration of ganglioside GM1 in animal models of both diseases results in significant attenuation of neurodegeneration and improvement of symptoms. In HD mice, these beneficial effects are associated with decreased brain accumulation of mutant huntingtin (mHTT), the toxic protein that causes HD. The underlying mechanisms are unknown, but preliminary data in our laboratory suggest that GM1 increases neuronal secretion of mHTT within extracellular vesicles (EVs), membrane-bound cell-derived particles with roles in cell-cell communication and immune modulation. I will test the hypothesis that cellular levels of gangliosides regulate the secretion of EVs containing toxic misfolded proteins, and that increased ganglioside levels and/or altered ganglioside profile on the surface of EVs facilitate their uptake and clearance by microglia and modulate microglia function towards neuroprotection. My studies will uncover a novel role for gangliosides in EV secretion under physiological and pathophysiological conditions, and will provide mechanistic insights on the neuroprotective role of GM1 in HD and in PD. This knowledge may accelerate translation of ganglioside-based therapies to clinical trials.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
406264
Name
Monyror John G
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Role of gangliosides in the secretion of extracellular vesicles in neurodegenerative disease
Programtype2
Studentship Programs
Orgnameinp2
University of Alberta
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Extracellular Vesicles; Gangliosides; Huntington'S Disease; Microglia; Neurodegeneration; Neuroprotection; Parkinson'S Disease
Abstract
Gangliosides are glycosphingolipids enriched in the brain with important roles in cell signaling, cell-cell communication and immune-modulation. Their levels are decreased in several neurodegenerative conditions, including Huntington’s disease (HD) and Parkinson’s disease (PD). Therapeutic administration of ganglioside GM1 in animal models of both diseases results in significant attenuation of neurodegeneration and improvement of symptoms. In HD mice, these beneficial effects are associated with decreased brain accumulation of mutant huntingtin (mHTT), the toxic protein that causes HD. The underlying mechanisms are unknown, but preliminary data in our laboratory suggest that GM1 increases neuronal secretion of mHTT within extracellular vesicles (EVs), membrane-bound cell-derived particles with roles in cell-cell communication and immune modulation. I will test the hypothesis that cellular levels of gangliosides regulate the secretion of EVs containing toxic misfolded proteins, and that increased ganglioside levels and/or altered ganglioside profile on the surface of EVs facilitate their uptake and clearance by microglia and modulate microglia function towards neuroprotection. My studies will uncover a novel role for gangliosides in EV secretion under physiological and pathophysiological conditions, and will provide mechanistic insights on the neuroprotective role of GM1 in HD and in PD. This knowledge may accelerate translation of ganglioside-based therapies to clinical trials.
Competitiondate
201812
Approvedterm2
1 yr 0 mth
Pinamesdelim
Monyror, John G
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~